Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@Tickeron 6
@optioncharts 5
@TradingChromat1 4
@stock_titan 3
@FastestAlert 3

Recent Tweets for INCY

TradingChromat1 @TradingChromat1
$INCY Awaiting Short Signal. Learn more at https://t.co/emZsi1kAMx https://t.co/P2xDBCsLfj
May 28th 2022, 8:05pm
optioncharts @optioncharts
$INCY Max Pain is 75.00 for maturity 06/17/2022. #maxpain #options https://t.co/YNyzDxPSBD https://t.co/TrrQimPPLF
May 28th 2022, 5:05pm
optioncharts @optioncharts
$INCY high OI range is 50.00 to 80.00 for option expiration 06/17/2022 PutCallRatio=0.99 #maxpain #options… https://t.co/HeEzrXNxSO
May 27th 2022, 5:05pm
TradingChromat1 @TradingChromat1
$INCY Awaiting Short Signal. Learn more at https://t.co/emZsi1kAMx https://t.co/AsvClicPSn
May 27th 2022, 4:05pm
ShortAlgoKing @ShortAlgoKing
$INCY Awaiting Short Signal ? Stock Trading Ideas by https://t.co/qchl9O5K2n https://t.co/qMHLLbZAbH
May 27th 2022, 11:05am
1stOncology @1stOncology
Data from #Incytes Robust and Progressing #Oncology Portfolio to be Presented at #EHA22 Annual Meeting $INCY https://t.co/bcF14L4hKD
May 27th 2022, 8:05am
MarcJacksonLA @MarcJacksonLA
$INCY Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting - https://t.co/FQRY1gjDmD
May 26th 2022, 8:05pm
Tickeron @Tickeron
$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/iWOibV6F2V
May 26th 2022, 5:05pm
LeeSinTrade1 @LeeSinTrade1
$INCY Stock Trading Ideas | Awaiting Buy Signal. >> Learn more at https://t.co/z9Zossz5Nf https://t.co/FZxAMq9dxP
May 26th 2022, 3:05pm
TradingChromat1 @TradingChromat1
$INCY Awaiting Short Signal. Learn more at https://t.co/emZsi1kAMx https://t.co/5vv9q2xdUo
May 26th 2022, 3:05pm
Tickeron @Tickeron
$INCY enters bullish trend #Incyte #stockmarket #stock https://t.co/AVT9tdtUIP
May 26th 2022, 2:05pm
JanetWa28178453 @JanetWa28178453
$INCY Don't miss the next move in a few hours.. https://t.co/MKGf5q327P
May 26th 2022, 2:05pm
Tickeron @Tickeron
$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on April 26, 2022. View od… https://t.co/K0xqfhOIHf
May 26th 2022, 1:05pm
MaiteMerenda @MaiteMerenda
$INCY Awaiting Buy Signal ? Stock Trading Ideas by https://t.co/t5kOjgsWN3 https://t.co/RJRNkzLW4g
May 26th 2022, 12:05pm
Gambiste1 @Gambiste1
RT @stock_titan: $INCY Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting https://t.co…
May 26th 2022, 10:05am
newsfilterio @newsfilterio
Data from Incyte's Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting $INCY https://t.co/egcIHN18XA
May 26th 2022, 10:05am
FlashAlert_me @FlashAlert_me
$INCY [15s. delayed]: Issued Press Release on May 26, 06:00:00: Data from Incyte’s Robust and Progressing Oncology… https://t.co/Atkuuyaj6s
May 26th 2022, 10:05am
otcdynamics @otcdynamics
$INCY Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting https://t.co/WQA7jBhc73
May 26th 2022, 10:05am
bot_chatty @bot_chatty
RT @FastestAlert: $INCY Data From Incyte’s Robust And Progressing Oncology Portfolio To Be Presented At 2022 EHA Annual Meeting Stock News…
May 26th 2022, 10:05am
StockNewsBot2 @StockNewsBot2
$INCY Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting https://t.co/EdtCMoHECB
May 26th 2022, 10:05am
FastestAlert @FastestAlert
$INCY Data From Incyte’s Robust And Progressing Oncology Portfolio To Be Presented At 2022 EHA Annual Meeting Stock News Alerts In Bio
May 26th 2022, 10:05am
stock_titan @stock_titan
$INCY Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting https://t.co/jjueTARn0X
May 26th 2022, 10:05am
UsMarketNews @UsMarketNews
$INCY news Data from Incyte's Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
May 26th 2022, 10:05am
JanetWa28178453 @JanetWa28178453
$INCY Don't miss the next move in a few hours. https://t.co/MKGf5q327P
May 26th 2022, 4:05am
TradingChromat1 @TradingChromat1
$INCY Awaiting Buy Signal. Learn more at https://t.co/emZsi1kAMx https://t.co/quTbUmzTzd
May 25th 2022, 4:05pm
Biomaven @Biomaven
@JD4for4 @drug_smolecules I’ve been told they don’t have freedom to operate until the $incy composition of matter p… https://t.co/XOJvL4EneX
May 25th 2022, 1:05pm
1stOncology @1stOncology
#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/5mtTZ6k4PQ
May 25th 2022, 9:05am
Tickeron @Tickeron
This is amazing! What do you think? $INCY MACD Histogram turned positive on May 23, 2022. #Incyte #stockmarket… https://t.co/2qnhMFbEjx
May 25th 2022, 3:05am
newsfilterio @newsfilterio
Incyte to Present at Upcoming Investor Conference $INCY https://t.co/H2N0rBScNM
May 25th 2022, 12:05am
Gambiste1 @Gambiste1
RT @jq1234t: @Biomaven Don’t think $INCY can develop oral ruxolitinib or follow-on compounds for AA because it licensed baricitinib and cer…
May 24th 2022, 12:05pm
jq1234t @jq1234t
@Biomaven Don’t think $INCY can develop oral ruxolitinib or follow-on compounds for AA because it licensed bariciti… https://t.co/DAUZ9pNAEX
May 24th 2022, 12:05pm
Biomaven @Biomaven
$INCY buying them would also resolve the pricing issue for Jakafi - well over $100k a year might be OK for a cancer… https://t.co/b0p2PJjc73
May 24th 2022, 12:05pm
otcdynamics @otcdynamics
$INCY Incyte to Present at Upcoming Investor Conference https://t.co/ab2ppMkrRU
May 24th 2022, 12:05pm
FlashAlert_me @FlashAlert_me
$INCY [15s. delayed]: Issued Press Release on May 24, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/g4NL8AV8mG
May 24th 2022, 12:05pm
StockNewsBot2 @StockNewsBot2
$INCY Incyte to Present at Upcoming Investor Conference https://t.co/xklkskwOmT
May 24th 2022, 12:05pm
WebChronicleTo1 @WebChronicleTo1
$INCY Incyte to Present at Upcoming Investor Conference https://t.co/txci11HXCR
May 24th 2022, 12:05pm
FastestAlert @FastestAlert
$INCY Incyte To Present At Upcoming Investor Conference Stock News Alerts In Bio
May 24th 2022, 12:05pm
stock_titan @stock_titan
$INCY Incyte to Present at Upcoming Investor Conference https://t.co/m7KwmyyKP0
May 24th 2022, 12:05pm
bthefirsttoknow @bthefirsttoknow
First out// $INCY: Incyte to Present at Upcoming Investor Conference https://t.co/jNgzB4BNLp
May 24th 2022, 12:05pm
Stock_Prophecy @Stock_Prophecy
$INCY Incyte Corporation: Reference Price 64.96, 1 Year Prediction 73.05, Potential 12.0%, #INCY
May 23rd 2022, 9:05pm
TradeWithAlerts @TradeWithAlerts
Nice print for $INCY Size: 137480 Price: 76.91 Amount: $10,573,586.80 Time: 1600 See more: https://t.co/upA3JTyTxv… https://t.co/7eFu69HKDa
May 23rd 2022, 8:05pm
communiststocks @communiststocks
Incyte Corp - $INCY ? QUOTE $INCY was UP ? on Fri May 20 Closed at 74.88 USD for a 0.73% gain from previous close… https://t.co/D5uDEeZwdK
May 23rd 2022, 7:05am
Tickeron @Tickeron
$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/I8rlTaj0ce
May 23rd 2022, 3:05am
optioncharts @optioncharts
$INCY Max Pain=72.50. Maturity=06/17/2022. #maxpain #options https://t.co/YNyzDxPSBD https://t.co/EJz8939Qr2
May 21st 2022, 10:05pm
MarcJacksonLA @MarcJacksonLA
$LLY $INCY CHMP Recommends Approval of Lilly and Incyte's OLUMIANT® (baricitinib) as the First and Only Centrally-A… https://t.co/pKT8DsnoEG
May 20th 2022, 7:05pm
MarketCurrents @MarketCurrents
$INCY $LLY - Lilly, Incyte's Olumiant get EMA panel nod for hair loss disorder alopecia areata https://t.co/Ni0fzqU8Zo
May 20th 2022, 1:05pm
thudderwicks @thudderwicks
$LLY, $INCY The European Commission's decision is expected in the next one to two months.
May 20th 2022, 12:05pm
thudderwicks @thudderwicks
$LLY, $INCY EMA's CHMP issues positive opinion for OLUMIANT https://t.co/MXAKNEAAej
May 20th 2022, 12:05pm
FlashAlert_me @FlashAlert_me
$INCY [15s. delayed]: Issued Press Release on May 20, 08:11:00: CHMP Recommends Approval of Lilly and Incyte's OLUM… https://t.co/Ic4dkxEZPO
May 20th 2022, 12:05pm
ZoZoStockwatch @ZoZoStockwatch
$LLY $INCY CHMP Recommends Approval of Lilly and Incyte's OLUMIANT® (baricitinib) as the First and Only Centrally-A… https://t.co/H3vF6CFkzd
May 20th 2022, 12:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.